
è¬ã ããã®ç·æ¥äœ¿çšèš±å¯
ãã®è³æã«ã¯ãYesãªã®ãNoãªã®ããã¯ã£ãããšããçããæžãããŠããŸããããå°åŠçã«é¢ä¿ãããšãŠãéèŠãªåé¡ã§ããããã«ãçããèããŠãããã¡ã«ãè¬ã ããã§ããããšãããããŸãããããã«ã€ããŠãçŽåŸã®ãã説æãã§ãã人ã¯ããã®ã§ããããã
FDAã®ãã¡ã¯ãã·ãŒã
ãã¡ã€ã¶ãŒç€Ÿã®æ¥æ¬æ³äººã¯ã11æ10æ¥ã«5æ³ãã11æ³ã«æäžããã³ããã¯ã¯ãã³ã®è£œé 販売æ¿èªãåçåŽåçã«ç³è«ãããšçºè¡šããŸãããã¢ã¡ãªã«ã§ã¯ãã§ã«ãåã©ããžã®ç·æ¥äœ¿çšãèš±å¯ãããæ¥çš®ãå§ãŸã£ãŠããŸãã
â»ç·æ¥äœ¿çšèš±å¯ã¯ãæ£åŒæ¿èªã§ã¯ãããŸããã
10æ29æ¥ãFDAïŒã¢ã¡ãªã«é£åå»è¬åå±ïŒã®ãµã€ãã§ããã¡ã€ã¶ãŒç€Ÿã®æ°åã³ããã¯ã¯ãã³ã«é¢ãããã¡ã¯ãã·ãŒããæŽæ°ãããŸããã5æ³ãã11æ³åãã®æ¥çš®ã«é¢ãããã¡ã¯ãã·ãŒãããå ¬éãããŠããŸãã
翻蚳ããããã¡ã¯ãã·ãŒãã®äžã«ã以åã¯æ¥æ¬èªããã£ãã®ã§ããããªããªã£ãŠããŸã£ãããã§ãã
è±èªã®ãã¡ã¯ãã·ãŒããèŠããšã次ã®ãããªè³ªåãšåçããããŸãã
HAS THE VACCINE BEEN USED BEFORE?
Millions of individuals 12 years of age and older have received the Pfizer-BioNTech COVID-19 Vaccine under EUA since December 11, 2020.
 In a clinical trial, approximately 3,100 individuals 5 through 11 years of age have received at least 1 dose of Pfizer-BioNTech COVID-19 Vaccine.
In other clinical trials, approximately 23,000 individuals 12 years of age and older have received at least 1 dose of the vaccine.
The vaccine that is authorized for use in children 5 through 11 years of age includes the same mRNA and lipids but different inactive ingredients compared to the vaccine that has been used under EUA in individuals 12 years of age and older and that has been studied in clinical trials.
The use of the different inactive ingredients helps stabilize the vaccine under refrigerated temperatures and the formulation can be readily prepared to deliver appropriate doses to the 5 through 11 year-old population.
質åïŒHAS THE VACCINE BEEN USED BEFORE?
ïŒãã®ã¯ã¯ãã³ã¯ããããŸã§ã«äœ¿çšãããããšããããŸããïŒïŒ
ãã®ãããªçåæã«ã¯ãYesãNoã§çããããã¯ãã§ãããYesãNoãèŠåœãããŸãããçµå±ãYesãªã®ã§ããããïŒããããšããNoãªã®ã§ããããïŒ
1ïŒPfizer-BioNTech COVID-19 Vaccineã¯ã2020幎12æããç·æ¥äœ¿çšèš±å¯ã®ããšã§ã12æ³ä»¥äžã«å¯ŸããŠã¯äœçŸäžãã®äººã«æ¥çš®ããŠããã
âäœçŸäžäººãæ¥çš®ããŠãããšèšã£ãŠããã ãã§ããã®äœçŸäžäººã®æ¥çš®åŸã«ã€ããŠã¯æžãããŠããŸããããã¡ã€ã¶ãŒç€Ÿè£œã¯æ£åŒæ¿èªããããšæã£ãŠããã®ã§ããããunder EUAïŒEMERGENCY USE AUTHORIZATIONïŒããšãªã£ãŠããã®ãæ°ã«ãªããŸãã
2ïŒèšåºè©Šéšã§ã¯ã5æ³ãã11æ³ã®çŽ3100人ãããã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ïŒPfizer-BioNTech COVID-19 VaccineïŒãå°ãªããšã1åæ¥çš®ããã
âãã£ã3100人ã§ãããããããå°ãªããšã1åæ¥çš®ããããšããã®ã§ã3100人ã®ãã¹ãŠã2åæ¥çš®ããããã§ã¯ãªãã®ã§ãããã
3ïŒå¥ã®èšåºè©Šéšã§ã¯ã12æ³ä»¥äžã®çŽ23000人ãå°ãªããšã1åæ¥çš®ããã
â12æ³ä»¥äžã¯23000人è¡ã£ãã®ã«ã5æ³ãã11æ³ã¯ãã£ã3100人ã§ãã
4ïŒ5æ³ãã11æ³ã®åã©ãã«äœ¿çšèš±å¯ãããã¯ã¯ãã³ã¯ãèšåºè©Šéšã§ç ç©¶ããã12æ³ä»¥äžã«ç·æ¥äœ¿çšãããŠããã¯ã¯ãã³ãšåãmRNAãšè質ãå«ãŸããŠããããäžæŽ»æ§æåãç°ãªãã
âä»å䜿çšèš±å¯ããããã®ã¯ãäœçŸäžäººãæ¥çš®ããŠãããã®ãšã¯æåãéããšèšã£ãŠããŸãã
5ïŒç°ãªãäžæŽ»æ§æåã¯ãå·èµæž©åºŠäžã§ã¯ã¯ãã³ãå®å®ãããã®ã«åœ¹ç«ã¡ããã®é
åã«ããã5æ³ãã11æ³ã®åã©ãã«é©åã«å±ããããšãå¯èœã«ãªãã
âå·èµä¿ç®¡ããããããããã«æåãå€ãããšããããšã§ããããã
5æ³ãã11æ³åãã®æåã«ã€ããŠã¯ãäžèšã®ããã«æžãããŠããŸãã
WHAT ARE THE INGREDIENTS IN THE VACCINE?
The vaccine includes the following ingredients: mRNA, lipids ((4-
hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol), tromethamine, tromethamine hydrochloride, sucrose, and sodium chloride.
äœãéããããããŸã§ã®æåãšæ¯ã¹ãŠã¿ãŸãããã
12æ³ä»¥äžåãã®ãã¡ã¯ãã·ãŒã
12æ³ä»¥äžã«æ¥çš®ãããã¯ã¯ãã³ã®ãã¡ã¯ãã·ãŒããã10æ29æ¥ã«æŽæ°ãããŠããŸããã
WHAT ARE THE INGREDIENTS IN THE VACCINES?
COMIRNATY (COVID-19 Vaccine, mRNA) and the authorized formulations of the vaccine include the following ingredients:
⢠mRNA and lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-
hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol).
Pfizer-BioNTech COVID-19 vaccines for individuals 12 years of age and older contain 1 of the following sets of additional ingredients; ask the vaccination provider which version is being administered:
⢠potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose
OR
⢠tromethamine, tromethamine hydrochloride, and sucrose
COMIRNATY (COVID-19 Vaccine, mRNA) contains the following additional ingredients:
potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.
æåã«é¢ããéšåãèŠããšãæ·»å å€ã2ãã¿ãŒã³ããã®ã§ãã©ã¡ãã®ããŒãžã§ã³ãã¯ã¯ãã³æäŸè ã«ç¢ºèªããŠããšæžããŠãããŸãã
ãã€ã2ãã¿ãŒã³ã«ãªã£ãã®ã§ããïŒïŒããã®ãã¡ã®1ãã¿ãŒã³ãã5æ³ãã11æ³åããšåãæåã®ããã§ãã
11æã«æ¹èšãããã³ãããã£çæ³šã®æ·»ä»ææžãèŠããšãæ¥æ¬ã§æ¥çš®ãããŠããã®ã¯åè ïŒ5æ³ãã11æ³åããšã¯éãïŒã®æ·»å å€ã®ããã§ãã
ãã¡ã¯ãã·ãŒãã«ã¯ãCOMIRNATYã«ã€ããŠããæ·»å å€ãæžãããŠããŸãã
ãã¡ã€ã¶ãŒç€Ÿè£œãFDAã§æ£åŒæ¿èªããããšãã«ãçåã ã£ãã®ã§ãããCOMIRNATYãšPfizer-BioNTech COVID-19 Vaccineã¯ãå¥ã®ãã®ãªã®ã§ããããïŒãFDAãæ£åŒæ¿èªããã®ã¯COMIRNATYã§ããã§ãããä»ãäžçã§æ¥çš®ãããŠããã®ãã©ã¡ããªã®ãããããŸãããæ¥æ¬ã§è²©å£²ãããŠãããã®ã¯ãã³ãããã£ç泚ããšåŒã°ããŠããŸãããããã¯æ£åŒæ¿èªãããåããã®åŒã³æ¹ã§ãã
8æã®ãã¡ã¯ãã·ãŒãã«ã¯ããand will now be marketed as ComirnatyããšæžãããŠããã®ã§ãããFDAããCOMIRNATYããšåŒã¶ãã®ã¯ãä»ãã¢ã¡ãªã«ã§ã¯æ¥çš®ãããŠããã®ã§ããããïŒããããšãããŸã å
ã®è©±ãªã®ã§ããããïŒ
ãããŠãä»åã5æ³ãã11æ³ã«å¯ŸããŠãPfizer-BioNTech COVID-19 Vaccineãã®ç·æ¥äœ¿çšèš±å¯ãåºããšæžãããŠããŸããã€ãŸãã12æ³ä»¥äžã«å¯ŸããŠç·æ¥äœ¿çšèš±å¯ãåºãŠããã¯ã¯ãã³ãã5æ³ãã11æ³ã«ãç·æ¥äœ¿çšãèš±å¯ããããšããããšã§ãã
The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to provide a two-dose primary series to individuals 5 through 11 years of age.
ããããçåãã§ãŠããŸãããæåã®è³ªåã«ãã©ããŸãã
12æ³ä»¥äžåãã®ãã¡ã¯ãã·ãŒãã«ãããHAS THE VACCINE BEEN USED BEFORE? ããšãã質åããããŸãã
HAS THE VACCINE BEEN USED BEFORE?
Yes. In clinical trials, approximately 23,000 individuals 12 years of age and older have received at least 1 dose of the vaccine. Data from these clinical trials supported the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccines and the approval of COMIRNATY (COVID-19 Vaccine, mRNA). Millions of individuals have received the vaccine under EUA since December 11, 2020. The vaccine that is authorized for use in individuals 12 years and older includes two formulations; one that was studied in clinical trials and used under EUA, and one with the same mRNA and lipids but different inactive ingredients. The use of the different inactive ingredients helps stabilize the vaccine under refrigerated temperatures and the formulation can be administered without dilution.
ãã¡ãã«ã¯åé ã«ãYesãšæžãããŠããŸãããªãã5æ³ãã11æ³åãã«ã¯YesãšæžããŠããªãã®ã§ããããïŒãã ãã ããšèª¬æããŠããŸãããçµå±ãYesã§ã¯ãªããšããããšãªã®ã§ãããã
ããã«ã12æ³ä»¥äžåãã®ãã¡ã¯ãã·ãŒãã«æ·»å å€ã2ãã¿ãŒã³ããããšãæžãããŠããŸããããã£ããããã€ãã2ãã¿ãŒã³ã«ãªããæ¥çš®ãããåŽã¯ã©ã¡ããªã®ãç¥ãããšã¯ã§ããã®ã§ããããïŒãè¬ã°ããã§ãã
å»çåŸäºè
åãã®ãã¡ã¯ãã·ãŒã
å»çåŸäºè
åãã®ãã¡ã¯ãã·ãŒãã«ã¯ã容åšã®èª¬æãªã©ããããŸãã
Pfizer-BioNTech COVID-19 Vaccine which is supplied in a multiple dose vial
with an orange cap and a label with an orange border, should not be used in individuals 12 years of age and older.
5æ³ãã11æ³åãã®ã¯ã¯ãã³ã¯ãªã¬ã³ãžãã£ããã§ãªã¬ã³ãžããŒããŒã®ãã€ã¢ã«ã«å ¥ã£ãŠããŠãã12æ³ä»¥äžã«ã¯äœ¿çšããªãã§ãã ããããšæžãããŠããŸããéãå°ãªããã广ãåºãªããããªã®ãããããŸãããã12æ³ä»¥äžåãã®ãã€ã¢ã«ã5æ³ãã11æ³ã«äœ¿çšããæ¹ãæãã§ãããã¡ãã®æ³šæã¯ããªãã®ã§ããããïŒããã¡ãã¡ã®æ¥çš®äŒå Žã§ãã¹ãå€çºããŠããã®ã§ãééããèµ·ããªãããšãŠãå¿é ã§ãã
11æ³ãš12æ³ã§åºåã£ãŠããŸãããäœæ Œãªã©ã¯é¢ä¿ãªãã®ã§ããããïŒã
è³æãèªãã°èªãã»ã©ãçåãã§ãŠããŸãã
ãããã®çåã«ãçŽåŸãããŸã§èª¬æããŠããããããã¯ãããŠãæ¥çš®ãåžæããŸããã«ãã§ãã¯ãå
¥ããããã®ã§ã¯ãªãã§ããããã


